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Background
The clinical appearance of Clostridium difficile infection
(CDI) has changed in the last three years in Romania, due
to the emergence of the hypervirulent ribotype 027 of
Clostridium difficile. It is a risk for less than optimal man-
agement of this disease, especially the severe CDI with
rapidly fatal outcome.
Case report
An overview of our 2011-2013 experience retrieved several
common mistakes of CDI management (e.g. almost 51% of
CDI patients received combined therapy with metronida-
zole and vancomycin, less than 25% colectomies for cases
with toxic megacolon, several secondary cases in patients
hospitalized in the same room with a non-diagnosed CDI
patient). We have chosen to present eight “pearls” that
summarize better the difficulties of CDI clinical and
microbiological diagnosis, medical and surgical treatment
and control infection measures; each of these ideas is
exemplified with situations from our practical experience.
Conclusion
Several common mistakes were identified in the manage-
ment of CDI, even in a tertiary hospital specialized in
infectious diseases. Medical continuous education based
on reliable information its needed for improvement of
CDI management.
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